Pelago Bioscience is pleased to participate in the ADDC 2025 Colloquium, taking place on October 28–29 at the Eric P. Newman Education Center (EPNEC), Washington University School of Medicine in St. Louis.
Meet our team: Dan Campbell (Regional Sales Director) and a Julia Popp (Project Advisor), at our tabletop exhibition in the refreshment and poster area to discuss how CETSA® can advance your research by providing functional, biologically relevant insights directly in cells.
Poster Presentation
Title: Employing CETSA® in primary screening for p53 binders
This poster highlights the use of CETSA® for identifying new compounds that bind p53, a key target in oncology research. By measuring target engagement in intact cells, CETSA® provides meaningful data that support early discovery and validation in academic and translational settings.
We look forward to connecting with academic researchers and innovators at ADDC 2025 to discuss how CETSA® can accelerate discovery efforts and bring biological relevance to screening programs.
Learn more about the event here.